Comparative Clinical and Economic Outcomes Associated with Warfarin Versus Apixaban in the Treatment of Patients with Venous Thromboembolism in a Large U.S. Commercial Claims Database.
J Manag Care Spec Pharm
; 26(8): 1017-1026, 2020 Aug.
Article
in En
| MEDLINE
| ID: mdl-32452277
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazoles
/
Pyridones
/
Warfarin
/
Insurance Claim Review
/
Health Care Costs
/
Venous Thromboembolism
Type of study:
Etiology_studies
/
Guideline
/
Health_economic_evaluation
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
America do norte
Language:
En
Journal:
J Manag Care Spec Pharm
Year:
2020
Document type:
Article
Country of publication: